Neurofeedback Training for PD
Launched by UNIVERSITY OF OXFORD · Aug 3, 2023
Trial Information
Current as of August 19, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Neurofeedback Training for PD," is focused on understanding how a special type of training called neurofeedback can help people with Parkinson's disease. The researchers want to see if this training can help patients learn to control certain brain activities that may be causing problems. They will compare the effects of neurofeedback training to a situation where no training is given, to see if there are any benefits from the training over time.
To participate, individuals must be either diagnosed with Parkinson's disease or be healthy individuals of similar age. Participants should be able to understand the study information in English and be willing to give their consent to join. During the study, participants will take part in up to three training sessions where they will press a device quickly while their brain signals are recorded. This will help researchers learn more about how effective neurofeedback training can be. The trial is not yet recruiting participants, but it is open to anyone between the ages of 6 to 74, regardless of gender.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants with symptomatic Parkinson's disease or age-matched healthy control
- • Adequate understanding of verbal explanation or written information given in English
- • Able and willing to give informed consent.
- • Normal or corrected-to-normal vision
- Exclusion Criteria:
- • Lack of capacity to consent (judged by the researcher taking consent as not having sufficient mental capacity to understand the study and its requirements)
About University Of Oxford
The University of Oxford, a prestigious institution renowned for its excellence in research and education, serves as a leading clinical trial sponsor dedicated to advancing medical science and improving patient care. With a rich history of innovation and a multidisciplinary approach, the university leverages its extensive expertise in various fields, including medicine, public health, and biomedical research, to conduct rigorous clinical trials. Collaborating with healthcare professionals, industry partners, and regulatory bodies, the University of Oxford aims to translate groundbreaking research findings into effective therapies and interventions, contributing to the global effort of enhancing health outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported